Recent consumer research by product development group AMC Global and OpinionRoute, LLC reveals the evolving preferences of ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less processed foods and soda, researchers say food and beverage companies are ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s ... the federal Food, Drug, and Cosmetic Act (“FDCA”), FDA is required to maintain an up-to-date list of drugs that ...

Yet food companies from Hershey to Hormel are waving off the impact of GLP-1 drugs, even as they’ve been dropping weight themselves. The volume of food those and other companies sell has ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...

Despite the declines, GLP-1 users reported a continued desire to consume processed foods, sodas, refined grains and beef. Only fruits, leafy greens and water showed an overall increase in consumption.